Up 125% in 5 years and yielding 6.5%! Are Aviva shares the FTSE’s best all-rounder?

Harvey Jones says Aviva shares have given investors plenty of dividend income and share price growth in recent years. Can their good form continue?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Diverse group of friends cheering sport at bar together

Image source: Getty Images

All hail ​Aviva (LSE: AV) shares! They’ve been a standout performer in the FTSE 100 in recent past, delivering impressive growth and robust dividends.

While some stocks give investors high income, and others deliver heaps of growth, Aviva has done both. In spades.

Over the past year, Aviva’s share price has risen a modest 13%. Over five years though, it’s up a mighty 125%. That’s roughly double the FTSE 100’s 58% gain over the same period. 

Can it continue to beat the FTSE 100?

Better still, Aviva has consistently offered an attractive dividend yield, typically ranging between 6% and 7%, compared to the FTSE 100 average of about 3.5%.​

Past performance figures should always be approached with caution, especially these. Five years ago, the world was in lockdown and markets were in freefall. I wouldn’t expect an established blue-chip operating in a mature and competitive market, as Aviva does, to deliver a similarly stellar return over the next five years.

There’s still plenty to admire. Full-year 2024 results, released on 27 February 2025, showed operating profit climbed 20% to £1.77bn. The board is aiming for £2bn by 2026. It als rewarded investors by hiking the total dividend per share by 7% to 35.7p.

The £3.7bn acquisition of Direct Line is expected to enhance Aviva’s market position, potentially making it the UK’s largest home insurer and a leading player in motor insurance. But let’s not count our chickens just yet. Mergers can be complicated and don’t always unleash the expected value.

As the cost-of-living crisis drags on, general insurance will remain intensively competitive, while today’s volatile stock markets could hit assets under management.

Typically, a strong share price run shrinks the dividend yield, but Aviva still pays 6.45% on a trailing basis. Forecasts suggest this could rise to 6.77% in 2025 and 7.28% in 2026. 

Dividend income and growth too

FTSE 100 financial rivals like Legal & General Group and Phoenix Group Holdings offer higher yields of 8.2% and 9.2% respectively, but their share price performance has been vastly inferior.

So can Aviva maintain its momentum? Its diversified product range across insurance, wealth and retirement leaving it nicely placed. It should benefit from the aging population, as people have to make more pension provision themselves.

Analysts aren’t getting too excited though. The median target price for Aviva shares over the next year is 590p, suggesting a modest increase of just under 5% from today. Combined with the yield, this implies a potential total return of around 12%. Good but hardly stellar.

I’m also concerned that some of the recent share price growth is down to takeover speculation, with European insurers including Generali, Allianz, Intact Financial and Tyrg rumoured to be hovering. CEO Amanda Blanc dismissed it all as “market chatter”.

Sadly, I could no longer describe Aviva shares as a bargain, with a price-to-earnings ratio of almost 24. I still think it’s arguably the FTSE 100’s finest all-rounder though and well worth considering today but with a long-term view.

Of course, that’s just my opinion and Aviva may be played out after recent successes but investors who consider it could happily reinvest those juicy dividends while they wait for its next run of form.

Harvey Jones has positions in Legal & General Group Plc and Phoenix Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »